Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. B. Ortqvist (Danderyd, Sweden). Vaccination and other preventive measures for community acquired pneumonia. Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis

Member's Comments

No comment yet.

Related content which might interest you: Vaccination and other preventive measures for CAP and HAP Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Effects of vaccination on clinical presentation of community acquired pneumonia (CAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Pneumococcal vaccination for preventing occupationally acquired infections in healthcare workers Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019 Simultaneous use of probiotics and vaccines for prevention of pneumonia and respiratory infections in servicemen Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 A worldwide perspective of nursing home pneumonia beside community acquired pneumonia Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Pneumococcal and influenza vaccine uptake in patients discharged from an acute medical hospital Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Diagnosis and management of community acquired pneumonia in adults Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines Year: 2020 Efficacy of vaccination to prevent pneumococcal infection in organized communities Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Management of community acquired pneumonia Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Management of community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Management of community acquired pneumonia audit Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Effectiveness of empirical treatment of community acquired pneumonia requiring hospitalization Source: Eur Respir J 2006; 28: Suppl. 50, 166s Year: 2006 Preventive measures for respiratory infections and tuberculosis Source: ERS Course 2018 - Respiratory Infections Year: 2018 The APO-audit in the primary health care of archangelsk region: the way to the effective therapy of community-acquired respiratory infections Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care Year: 2009 Determinants of hospital costs in community acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Clinical and epidemiological assessment of the regional program of vaccination for pneumococcal infections Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Source: Eur Respir J 2011; 38: 878-887 Year: 2011